Search clinical trials for: intermediate and high risk cancer of the prostate
Total 494631 results
-
Ontario Clinical Oncology Group (OCOG)Canadian Institutes of Health Research (CIHR); Trans Tasman Radiation Oncology...Completed
-
Onconova Therapeutics, Inc.CompletedMyelodysplastic SyndromeUnited States
-
Onconova Therapeutics, Inc.WithdrawnMyelodysplastic SyndromeUnited States
-
UNC Lineberger Comprehensive Cancer CenterSanofiCompleted
-
University of Michigan Rogel Cancer CenterNovartis PharmaceuticalsTerminatedProstate CancerUnited States
-
OHSU Knight Cancer InstituteUnited States Department of Defense; Oregon Health and Science University; Portland...Completed
-
National Cancer Institute, NaplesCompleted
-
Molecular Insight Pharmaceuticals, Inc.CompletedProstate CancerUnited States, Belgium, Italy, Czech Republic, Hungary, Netherlands, Poland, Russian Federation
-
John P. FruehaufSanofiWithdrawnProstate Cancer | Stage I Prostate Cancer | Stage II Prostate Cancer | Adenocarcinoma of the Prostate
-
Sidney Kimmel Cancer Center at Thomas Jefferson...Completed
-
Sergio FariaCompletedHigh Risk Prostate CancerCanada
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)Withdrawn
-
AHS Cancer Control AlbertaUnknown
-
CureVacTerminated
-
Institut du Cancer de Montpellier - Val d'AurelleCompleted
-
Mary-Ellen Taplin, MDSanofi; Beth Israel Deaconess Medical Center; Genentech, Inc.; Duke UniversityCompletedProstate Cancer | Adenocarcinoma of the ProstateUnited States
-
Proton Collaborative GroupTerminatedProstate CancerUnited States
-
University of WaterlooGrand River Regional Cancer CentreCompleted
-
Groupe Francophone des MyelodysplasiesCelgene CorporationUnknownAcute Myeloid Leukemia | Chronic Myelomonocytic Leukemia | Myelodysplastic SyndromeFrance
-
Ginna LaportTerminatedAcute Myelogenous Leukemia (AML) - Relapsed, Primary Refractory Disease or Poor Risk Factors | Chronic Myelogenous Leukemia (CML) - Accelerated or Second Chronic Phase | Myelodysplastic Syndrome (MDS) - High and Intermediate Risk | Non-Hodgkin's Lymphoma (NHL) | Chronic Lymphocytic Leukemia...United States
-
Hospital de CrucesUnknown
-
H. Lee Moffitt Cancer Center and Research InstituteSanofiTerminatedProstate CancerUnited States
-
Centre Georges Francois LeclercTerminated
-
Benaroya Research InstituteGenentech, Inc.CompletedProstate CancerUnited States
-
European Organisation for Research and Treatment...Terminated
-
EDAP TMS S.A.UnknownProstate CancerUnited States, Canada
-
Myrexis Inc.UnknownProstate CancerUnited States
-
Virginia Commonwealth UniversityWithdrawnProstate CancerUnited States
-
National Cancer Institute (NCI)Eastern Cooperative Oncology Group; Southwest Oncology GroupCompletedLow, Intermediate, or High Dose Suramin in Treating Patients With Hormone-Refractory Prostate CancerProstate CancerUnited States, South Africa
-
Jonsson Comprehensive Cancer CenterNational Cancer Institute (NCI)Completed
-
National Taiwan University HospitalUnknown
-
M.D. Anderson Cancer CenterWithdrawn
-
AstraZenecaCompletedProstatic NeoplasmsUnited States
-
Benaroya Research InstituteSanofi; AstraZenecaCompletedProstate CancerUnited States
-
SanofiCompletedProstatic NeoplasmsUnited States, France, Brazil, Russian Federation, Australia, Turkey, India, Austria, Israel, Italy, Mexico, United Kingdom, Germany, Poland, Netherlands, South Africa, Canada
-
John Chang, MDUnknownProstate AdenocarcinomaUnited States
-
Centre Francois BaclesseTerminatedProstate Cancer With Intermediate RiskFrance
-
PhotocureKarl StorzCompletedIntermediate or High-risk Bladder Cancer
-
Kansas City Veteran Affairs Medical CenterSanofiUnknown
-
Sheba Medical CenterUnknown
-
US Department of Veterans AffairsCompletedProstate CancerUnited States
-
Maria Sklodowska-Curie National Research Institute...Not yet recruiting
-
Dana-Farber Cancer InstituteNot yet recruitingCancer Predisposition Syndrome | Predisposition, GeneticUnited States
-
The Swedish School of Sport and Health SciencesKarolinska Institutet; Sahlgrenska University Hospital, Sweden; Prostate Cancer... and other collaboratorsRecruiting
-
Uppsala UniversitySahlgrenska University Hospital, Sweden; University Hospital, Umeå; Uppsala University... and other collaboratorsNot yet recruiting
-
Ohio State University Comprehensive Cancer CenterRecruiting
-
City of Hope Medical CenterNational Cancer Institute (NCI)RecruitingThyroid Gland Follicular Carcinoma | Thyroid Gland Papillary Carcinoma | Thyroid Gland Oncocytic CarcinomaUnited States
-
Anhui Provincial Cancer HospitalHutchison Medipharma LimitedRecruiting
-
European Association of Urology Research FoundationNational Cancer Institute (NCI); UMC Utrecht; Erasmus Medical Center; University... and other collaboratorsNot yet recruiting
-
Fudan UniversityNot yet recruitingNeoadjuvant Therapy | Early Breast Cancer | TNBC, Triple Negative Breast CancerChina